Related references
Note: Only part of the references are listed.Classification Model for the Second Extracellular Loop of Class A GPCRs
Alessandro Nicoli et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
Recent progress in assays for GPCR drug discovery
Shimeng Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)
G protein-coupled receptor 21 in macrophages: An in vitro study
Valentina Bordano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Modifications in GPR21 and GPR82 genes expression as a consequence of metabolic syndrome etiology
Rodrigo Romero-Nava et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2021)
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
Melissa K. Thomas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges
Julien Ghislain et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
Darren M. Riddy et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Constitutive G protein coupling profiles of understudied orphan GPCRs
Sumin Lu et al.
PLOS ONE (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes
Congcong Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structural basis of ligand recognition and self-activation of orphan GPR52
Xi Lin et al.
NATURE (2020)
Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
Xiling Lin et al.
SCIENTIFIC REPORTS (2020)
Targeted Proteomics Combined with Affinity Mass Spectrometry Analysis Reveals Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan Receptor GPR52
Mengna Ma et al.
ACS CHEMICAL BIOLOGY (2020)
G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Darren M. Riddy et al.
PHARMACOLOGICAL REVIEWS (2018)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The PI3K/AKT pathway in obesity and type 2 diabetes
Xingjun Huang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
Fiona Bragg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
Arun Chaudhury et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Shilpa N. Bhupathiraju et al.
CIRCULATION RESEARCH (2016)
Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production
Ling He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Regulating the effects of GPR21, a novel target for type 2 diabetes
Siobhan Leonard et al.
SCIENTIFIC REPORTS (2016)
Gq-Coupled Receptors in Autoimmunity
Lu Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys
Ana Ortega-Molina et al.
CELL METABOLISM (2015)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Prevalence and Determinants of Overweight, Obesity, and Type 2 Diabetes Mellitus in Adults in Malaysia
Hamid Jan B. Jan Mohamed et al.
ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH (2015)
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality: a study in Tuscany, Italy, over years 2004-2011
Laura Policardo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Constitutive Activity among Orphan Class-A G Protein Coupled Receptors
Adam L. Martin et al.
PLOS ONE (2015)
Sequence-structure based phylogeny of GPCR Class A Rhodopsin receptors
Kavita Kumari Kakarala et al.
MOLECULAR PHYLOGENETICS AND EVOLUTION (2014)
Shifts in population dietary patterns and physical inactivity as determinants of global trends in the prevalence of diabetes: An ecological analysis
C. Oggioni et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets
Xiao-long Tang et al.
ACTA PHARMACOLOGICA SINICA (2012)
G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response
Jonitha Gardner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The structure and function of G-protein-coupled receptors
Daniel M. Rosenbaum et al.
NATURE (2009)
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction
Katsutaro Morino et al.
DIABETES (2006)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Identification of signal transduction pathways used by orphan G protein-coupled receptors
JN Bresnick et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2003)
Identifying the links between obesity, insulin resistance and β-cell function:: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes
AS Greenberg et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)